Netherlands Cancer Institute
Industry
- Academic and Research Institutions
Latest on Netherlands Cancer Institute
Boehringer Ingelheim GmbH presented Phase Ib results and Bayer AG reported Phase I/II data for their HER2 inhibitors at World Conference on Lung Cancer (WCLC) that showed greater response rates for
The quarterly Venture Monitor report from Pitchbook and the National Venture Capital Association (NVCA) reported biopharma start-ups raised $5.9bn in the first quarter of 2024 – more than the sector r
It may not be as easy for private biopharmaceutical companies to raise a new venture capital round in 2023 as it was during the past few years, but VC firms have brought in an impressive amount out ca
Germany’s BI Licenses Tumor-Specific Antibodies From Singapore Lab Boehringer Ingelheim GmbH and Singapore’s Agency for Science, Technology and Research (A*STAR) unveiled a global licensing agreem